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ABSTRACT
Phenylketonuria is an inborn error of metabolism, in which a restricted protein diet is the
primary treatment. High fat diets and obesity are two indicators of increased cardiovascular
disease (CVD) risk. Therefore, the aim of this study was to use high fat intakes and obesity to
investigate whether individuals with PKU were at an increased risk of CVD. Percentages of
calories coming from fat (PCF), BMI, body mass index percentages (BMI%), and weight per
lengths (WPL) were obtained on participants between the ages of 1-50 years old. In conclusion,
this study did not identify a risk for CVD in its participants as all studied variables were found to
be low. Although no increased risk was identified, this study recognizes that the PKU population
should maintain not only protein, but also fat and other nutrients, as they sustain a healthy life,
preventing serious complications such as obesity and CVD from arising.
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CHAPTER 1
LITERATURE REVIEW

Phenylketonuria
The number of defects that can occur in the human body is not limited and can include
defects that affect proper enzymatic function. Phenylketonuria (PKU) is an inborn error of
metabolism in which the phenylalanine hydroxylase (PAH) enzyme is defected. With this
enzymatic defect, the conversion of phenylalanine to tyrosine is altered (Figure 1), resulting in
high serum and brain phenylalanine levels. Untreated PKU can lead to a number of serious
complications such as intellectual disability, seizures, delayed development, and psychiatric
disorders. In order to prevent serious complications of untreated PKU, it was mandated in the
United States of America for PKU to be tested on newborn screenings, allowing for early
intervention and treatment.1,18,22,28

Hammons, m. Nutrient intake and body composition in children with phenylketonuria. Oregon health and science University School of Medicine;
2015.

Figure 1: Conversion of phenylalanine to tyrosine by phenylalanine hydroxylase44
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Phenylalanine
Amino acids are the building blocks of proteins,18 and consist as two types: essential and
nonessential. An essential amino acid cannot be made in the body; therefore, must be consumed
through the diet. Phenylalanine is an essential amino acid that can be found in three forms: Lphenylalanine, D-phenylalanine, and DL-phenylalanine. The best sources of L-phenylalanine,
found naturally in proteins, would include protein containing foods, such as beef, poultry, pork,
fish, milk, yogurt, eggs, cheese, soy products, nuts, and seeds.31 Aspartame, one of the most
common artificial sweeteners, is formed from phenylalanine, aspartic acid, and methanol.32,33 Two
brands of artificial sweeteners containing aspartame are NutraSweet and Equal.32
Dietary Treatment of PKU
One of the main treatments for PKU is restricting the protein in the diet to maintain low
blood phenylalanine levels. This can be achieved by being on a phenylalanine-free formula, a
low-protein diet, and a low-aspartame diet.1,22,28 The level of diet restriction depends on the
severity of the PAH enzymatic defect.2 Maintaining a steady treatment, which includes
monitoring nutrient consumption, purchasing more expensive, low-phenylalanine food items,
and attending a number of visits with various health professionals, requires a lot of planning.
There is no cure for PKU; however, with proper treatment, symptoms and other serious
complications can be managed.3,22
Compliance with the PKU Diet
Since food is so important to life and social interactions, an individual with PKU can
easily struggle with maintaining the proper restricted diet. Compliance of the diet can be a hard
task; it involves a lot of planning and self-control.4 Being on this diet can also cause a lot of
emotional distress as patients are not able to eat the same as their family and friends.26
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The Amount of Fat in the PKU Diet
Although individuals diagnosed with PKU must be on a low-protein diet based on their
individualized needs, the amount of fat and calories they can consume is based on their
recommended dietary intake, like that of healthy individuals. Recommended dietary intakes are a
national standard, based on gender and age, which can be found in Figure 2.3,6 Foods rich in
protein, such as meat, fish and dairy products, typically provide significant amounts of fat to the
diet.5 Therefore, individuals on the PKU diet are likely to consume less fat because of the diet’s
protein exclusion.5,6,27

The Office of Disease Prevention and Health Promotion. Dietary Guidelines for Americans 2015-2020, Eighth Edition, Nutritional Goals for
Age-Sex Groups Based on Dietary Reference Intakes & Dietary Guidelines Recommendations. Internet:
https://health.gov/dietaryguidelines/2015/resources/2015-2020_Dietary_Guidelines.pdf (Accessed on 29 March 2017).

Figure 2: Dietary Reference Intakes of Fat45

As well as being on a low-protein foods diet, children and adults are put on
phenylalanine-free formulas. For the first year of life, children are put on infant phenylalaninefree formulas, in combination with typical infant formula, providing all the necessary
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micronutrients and macronutrients. With age, the child is placed on a different formula,
providing the appropriate nutritional needs for their growth into early adulthood. Since the needs
of individuals differ, these formulas can have various compositions, unlike infant formulas which
are typically more consistent in composition.2 Resistance to changing formulas due to comfort
and consistency has been shown by individuals diagnosed with PKU. This indicates that these
individuals prefer their infant formulas, containing a higher fat content, over the adult formulas.8
However, as recommended, at one year of age, it is routine to move children from their infant
formulas, which offer 40-50% of their energy from fat, onto a more protein dense,
phenylalanine-free formula. If this change is made, it is likely that these individuals will
consume less fat, but more carbohydrate.9
Also, an important part of being on the low-phenylalanine diet is that each individual
must see doctors and dietitians in order to decide on the best diet plan for their individualized
needs, maintaining adequate protein, phenylalanine, and tyrosine levels.5 These individuals are
not seeing healthcare providers for the purpose of specifically maintaining the other
macronutrients and micronutrients.5 Therefore, meeting the needs of the other macronutrients,
such as fat, and micronutrients can be a bit more complicated.5,27 It has been shown that the risk
of essential fatty acid deficiencies and low polyunsaturated fatty acid intakes are common for
both children and adults with PKU.5 Although this conclusion is consistent with a number of
studies,5, 6 there are studies that showed an opposite result. With use of the BodPod airdisplacement plethysmography method, individuals with and without PKU had their fat
composition and body mass index (BMI) compared. No difference in BMI was found between
the two groups; however, a higher fat percentage was found in children with PKU, especially in
girls aged eleven years or older.7 As represented through the results of various previous
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studies,5,6,7,8,9 there are many different factors affecting individualized fat consumption;
therefore, the amount of fat consumed by PKU diagnosed individuals cannot be specified.6
Obesity Prevalence in PKU Diagnosed Individuals
In 2012, a study performed in Ohio and Texas revealed that females with PKU are
typically more obese than males with PKU. This study showed that 55% of 42 females were
overweight, while only 27% of 45 males were overweight. Out of the 55% of overweight
females, 33% were obese.30
The PKU diet is mainly composed of fruits and vegetables, which can appear to be
healthier; however, children with PKU are likely to eat more foods higher in calories, such as
some candy, because they are phenylalanine free.2 Individuals with PKU are also likely to
consume a higher intake of carbohydrates, making them more susceptible to obesity.30
Risk Factors and Proper Diet Compositions for the Prevention of CVD
There are a number of CVD risk factors, both modifiable and non-modifiable (Table 1).
Modifiable risk factors can be treated or changed, but non-modifiable risk factors cannot.48 Poor
nutrition, dyslipidemia, hypertension, diabetes mellitus, tobacco use, physical inactivity, and
obesity account for 75-90% of cardiovascular disease (CVD) in the United States of America.10
The American Heart Association (AHA) stresses a diet full of fruits, vegetables, whole-grains,
low-fat or nonfat dairy, beans, fish and lean meat for reducing the risk of CVD. Maintenance of
normal weight for height, adequate nutrient intake, and a low intake of trans and saturated fats is
also recommended by the AHA for lowering the risk of CVD.16
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Table 1: Modifiable and Non-Modifiable Risk Factors of CVD* 48
Modifiable Risk Factors:
Hypertension

Type 2 Diabetes

Abnormal blood lipid levels

High saturated fat diet

Tobacco use

Stress, social isolation, anxiety, depression

Physical inactivity

Alcoholism

Medications

Obesity

Non-Modifiable Risk Factors:
Age

Gender

Family history

Ethnicity

*CVD: Cardiovascular Disease
World Heart Federation. Cardiovascular disease risk factors. Internet: http://www.world-heart-federation.org/cardiovascularhealth/cardiovascular-disease-risk-factors/ (Accessed 26 November 2016).

Associated Risks of Fat and CVD
Dietary pattern and quality play a vital role in protecting against serious disease states,
such as CVD.12,20 An associated risk between a high intake of fat and CVD has been shown.11,20
This proves consistent as other studies have proved that a high vegetable diet can lower the risk
of CVD.12 Decreasing the risk of CVD has been linked to a number of dietary strategies, such as
substituting unsaturated fats for saturated and trans-fats, increasing consumption of omega-3
fatty acids from fish oil or plant sources, and consuming a high-fruits, vegetables, nuts, whole
grain diet. The risk of CVD is decreased more effectively by a combination of these three
strategies.13
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Associated Risks of Obesity and CVD
Obesity has been found to be a leading cause of CVD, with an impact on coronary artery
disease, congestive heart failure, arrhythmias, and sudden cardiac death.10,23 An excessive
amount of body fat can raise blood cholesterol levels, blood triglyceride levels, and blood
pressures. It has also been shown to cause diabetes, lower HDL levels, and affect blood
circulation and fluid levels, which all contribute to a higher risk of CVD. Unfortunately, an
average of 30% of adults and 16.9% of children in the United States are obese.34 As conveyed in
a previous study, an addiction to food has been blamed as one of the causes of obesity.
Individuals who are overweight and obese were asked to define food addiction, in which lack of
control and the accessibility to junk food were mentioned.35 Although, the AHA recommends
that a diet high in fruits and vegetables, while low in saturated fat, trans fat, and added sugar is
best for the prevention of CVD,10,13 this may be a hard diet to follow for those with obesity.35
Prevalence of CVD in PKU Diagnosed Individuals
The question of whether or not PKU diagnosed individuals have a higher risk of
developing CVD has arisen.15,19 The PKU diet is plant-based, meaning an increased consumption
of fruits and vegetables.14 As mentioned before, a diet of fruits and vegetables helps decrease the
risk of CVD;13 therefore, there is evidence indicating that the PKU population are living a
healthier lifestyle, reducing the likelihood of obesity and CVD.14
On the contrary, there are also common practices by individuals with PKU that have
shown to increase CVD risk. For example, as mentioned before, individuals with PKU are likely
to consume a large number of high sugar foods and beverages, which are low in phenylalanine.
This increases caloric intake and weight gain, causing an increase in obesity and CVD risk.14
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Although the PKU diet is specific, there is no evidence proving that the individuals on
this diet are following it perfectly, and therefore, it cannot be certain that nutrients are being
consumed as recommended.15 Therefore, studying the prevalence of high fat intakes and obesity,
two risk factors to CVD,15 will help to better analyze the risk of CVD in this population.
CHAPTER 2
SUBJECTS AND METHODS

Purpose
This study looked at the percentage of calories coming from fat (PCF), BMI, body mass
index percentages (BMI%), and weight per length (WPL) values of children and adults with
PKU. By using these variables, this study determined whether or not this population was at a
higher risk for developing CVD.
Location and Timeline
This thesis was carried out in Memphis, Tennessee at The University of Tennessee
Health Science Center’s Boling Center for Developmental Disabilities (UTHSC BCDD) and The
University of Memphis from January to November of 2017.
Medical Record Accessibility
This thesis was a retrospective chart review study. Medical records for participants were
obtained from the office of nutrition at the BCDD. Approval from the institutional review boards
at both the UT BCDD and the University of Memphis were obtained, see Appendix 2 and
Appendix 3.
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Budget
All participants were patients at the UTHSC BCDD and were not paid for participating in
this study. All information obtained for the study, including access to medical charts, was
obtained from the BCDD, with no cost.
Tools
Several tools were used for the performance of this study. First, MetabolicPro (Genetic
Metabolic Dietitians International), an online nutrient analysis software, was used by the
metabolic dietitian to analyze food records. Various anthropometric scales were also utilized to
obtain weight, height, BMI, BMI%, and WPL information. Both BMI% and WPL data obtained
from medical records were indicated as percentile ranges; therefore, the online website,
PediTools.org, was used to obtain exact BMI and WPL percentages by inserting participant age,
gender, height, and length information. PediTools is an online website that allows
anthropometrics to be inserted and compared to different growth charts. Microsoft Excel
Statistics (Microsoft, 2015) was used for the data collection process, patient stratification, and
statistical analysis.
Dietary Intake and Analysis
At the UTHSC BCDD, patients or their guardians were asked to bring a three-day food
record to every appointment they had with the dietitian. All foods and drinks, including formula,
consumed the three days directly before the appointment were noted on the three-day record.
These three-day food records were then analyzed using an online program called MetabolicPro
(Genetic Metabolic Dietitians International). The dietary analysis provided calories, protein, fat,
carbohydrates, percentage of energy coming from each macronutrient, and micronutrients. For
purposes of this study, PCF data was collected. All food records used in this study were analyzed
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using MetabolicPro between 2010-2017. The data collected was noted on the Microsoft Excel
Thesis Data Collection and Analysis spreadsheet found in Appendix 1.
Anthropometric Measurements and Analysis
At each participant appointment with the dietitian at the UTHSC BCDD, anthropometric
measurements, such as weight and height, were taken by the nursing staff. To obtain height, the
nurse assisted each participant to stand in front of a stadiometer. Height measurements were
taken in both centimeters and inches. The nurse then converted the height measurements to feet
and inches. The height measurement was then inserted into a computer system, which was
connected to a floor scale. Next, the nurse assisted the individual onto the large floor scale,
which then indicated on the computer what the participant’s weight and BMI were. The nurse
made note of the participant’s height, weight, and BMI, which the nurse also converted to a
percentile, and recorded it in the patient’s chart. For participants two years old and younger, a
length measurement was taken through an infantometer. This length measurement was then
compared to the child’s weight through growth charts, obtaining the participant’s weight per
length percentile.
Obesity Based on BMI, BMI%, and WPL
BMI is a ratio of body weight, in kilograms, and height, in meters. Found in participant
medical records, BMI data was collected and inserted into the Microsoft Excel Thesis Data
Collection and Analysis spreadsheet (Appendix 1). This data was collected on participants
nineteen years and older. Based on BMI, participants were categorized by normal weight,
underweight and overweight, indicated in Figure 3. This study focused on identifying
participants that had a BMI ≥30 kg/m2. Any differences in obesity between males and females
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nineteen years and older were also identified by performing the same analysis but on each gender
separately.

"About Adult BMI." Centers for Disease Control and Prevention. 15 May 2015. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/
(accessed: 25 May 2017).

Figure 3: Weight categories based on BMI46

BMI% data was collected for analysis on participants between the ages 3-18. A BMI%,
obtained by plotting BMI and age on growth charts, represents the comparison of an individual’s
BMI% value to that of other individuals who share the same gender and age.47 At the BCDD, a
BMI% range is noted; therefore, PediTools was used to obtain exact percentages by plugging in
participant’s age, gender, weight, and height values. The exact BMI% values were then
categorized to weight status categories using Figure 4.
A height measurement is not indicated in the two years and younger population, as a
length measurement is. Therefore, a BMI measurement was not able to be calculated. In this age
group, WPL percentiles were used instead of BMI. Similar to BMI%, WPL was noted at the
BCDD in medical records as a range. Therefore, each participant’s weight, length, and gender,
found in medical charts, were plugged into PediTools to obtain exact WPL percentiles. In this
study, the WHO (0-24 months) growth chart was used for participants younger than twenty-four
months. The weight and height of any individual between twenty-four and thirty-six months
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were plotted on the CDC (0-36 months) growth chart. Then, WPL measurements were compared
to the statistics found in Figure 4.

“About Child & Teen BMI." Centers for Disease Control and Prevention. 15 May 2015.
https://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html (accessed: 25 May 2017).

Figure 4: Weight categories based on WPL and BMI%47

CVD Risk Factors
Although there are many different risks of CVD48, this study only looked at obesity and
fat intake. For the purpose of this study, obesity was analyzed through BMI, BMI% and WPL
statistics and fat intake was analyzed through PCF. Lower BMI, BMI%, WPL, and PCF values
indicated a lower risk for CVD. While opposite, a higher BMI, BMI%, WPL, and PCF indicated
a higher risk for CVD.
Study Population and Recruitment
This study aimed to collect data for thirty-seven individuals for participation in this study.
Table 2, shown below, indicates this study’s inclusion requirement for participation. Individuals
who were not diagnosed with PKU, not within the required age range, and did not have at least
10 of either PCF or BMI, BMI%, WPL data available for use in their medical chart were
excluded from the study. This was determined by accessing a list of patients seen by the dietitian
at the UTHSC BCDD.
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Table 2: Inclusion Requirements for Test Subject Recruitment
Inclusion:


Between the ages 1-50 years



Diagnosed with PKU*



Started on a low-phenylalanine diet since birth



Treated at the University of Tennessee Boling Center for Developmental Disabilities



Has 10 food record and/or anthropometric measurements available for use in medical chart

*PKU: Phenylketonuria

Patient Stratification
Using Figure 2, participants were divided into different age groups (Group 1, 2, and 3)
based on their recommended PCF ranges (Table 3). Both male and females between the ages of
one and three years old are recommended to have a PCF of 30-40%; therefore, formed Group 1.
Having a PCF recommendation of 25-35%, males and females between the ages of four and
eighteen formed Group 2. A PCF of 20-35% is recommended for males and females between the
ages of nineteen and fifty, so these participants formed Group 3. The same age groups were used
for the BMI, BMI%, and WPL analysis. However, length measurements are taken on individuals
younger than the age of two, as they are too young for height measurements; therefore, WPL
data was collected. Due to this, participants in Group 1 were further divided into two separate
groups: 1-2 years old (Group 1a) and 2-3 years old (Group 1b).
Each group in this study was further divided for the gender specific analyses. The males
and females in each group were separated into their own groups, forming six new groups. For
each participant, the aim was to collect a data set of ten PCF and ten BMI, BMI%, or WPL
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values, which were obtained at different times within the individual’s life. Therefore, participants
were likely to be included into more than one group.

Table 3: Patient Stratification Based on Age and Fat Recommendations
Group Number and Age Range

Recommended PCF* Ranges

Group 1: 1-3 years old

30-40%

Group 2: 4-18 years old

25-35%

Group 3: 19-50 years old

20-35%

*PCF: Percentage of Calories Coming from Fat

Statistical Analysis
The statistical analysis included the use of confidence intervals, which were constructed
for the mean values of the PCF, BMI, BMI%, and WPL variables. If needed, a multivariate t-test,
or Hoteling T2, was used in order to test whether the variable’s means were equal to the
recommended values within each age group. A multivariate test was also suggested to take into
consideration the possible correlation between PCF and BMI measures. Individual t-tests were
also used in this study, testing PCF values to the lower and upper limits of the recommended
ranges for each age group (Table 1), BMI to ≥30 kg/m2, BMI% to ≥95%, and WPL to ≥95%. All
tests performed in this study were two-sided.
Gender Specific Statistical Analysis
For purposes of this study, the three groups of participants were further divided based on
gender, forming six new groups. A statistical analysis was performed on each of these gender
specific formed groups. Confidence intervals were performed to compare the recommended
PCF, BMI, WPL, and BMI% values to the participant’s values. The individual t-tests were
performed to test PCF values to the lower and upper limits of the recommended range, BMI% to
14

≥95%, WPL to ≥95%, and BMI values to ≥ 30. If the results of the individual t-tests were not
clear and if correlations were not high, then the Hoteling T2 was used. Also, individual t-tests
were performed to compare tested variables between male and female groups.
CHAPTER 3
RESULTS

Subject Characteristics
Although the aim of this study was to include thirty-seven participants, there were a total
of thirty-eight participants, ranging from 1 to 50 years old. With realization that collecting ten
records for every participant was not feasible, it was required that every participant had at least
one appointment with the metabolic dietitian at the UTHSC BCDD, where either three-day food
records and/or anthropometric measurements were obtained.
Stratification of Participants
This retrospective study collected data from different times throughout participants’ lives;
therefore, some participants had data that fell into more than one age group. For the PCF
analyses, eight participants were included in Group 1, nineteen participants in Group 2, and
nineteen participants in Group 3 (Table 4). Although the same ages were grouped together, the
participants within each group varied between the BMI, BMI%, WPL, and PCF analyses. Six
participants, having WPL data, formed Group 1a (Table 5). Two two-year olds had both WPL
and BMI% data noted in their charts. These two participants were therefore included in both
Group 1a and Group 1b. With BMI% data, six individuals formed Group 1b and nineteen
participants formed Group 2. Nineteen participants, who had BMI data, formed Group 3, as seen
in Table 5.
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Table 4: PCF* Analyses Participants
Measure

Group

n (Participants)

Gender Ratio

Total Number of Records

PCF

Group 1

8

7 Males : 1 Female

62

PCF

Group 2

19

11 Males : 8 Females

124

PCF

Group 3

19

6 Males : 13 Females

108

*PCF: Percentage of Calories Coming from Fat

Table 5: WPL*, BMI%**, and BMI*** Analyses Participants
Measure

Group

n (Participants)

Gender Ratio

Total Number of Records

WPL

Group 1a

6

5 Males : 1 Female

43

BMI%

Group 1b

6

6 Males : 0 Females

34

BMI%

Group 2

19

11 Males : 8 Females

138

BMI

Group 3

19

6 Males : 12 Females

95

*WPL: Weight Per Length
**BMI%: Body Mass Percentile
***BMI: Body Mass Index

95% Confidence Intervals Comparing PCF to Recommended
Group 1
A 95% confidence interval was computed for PCF, resulting in lower and upper
confidence limits of 23.37% and 29.06%. The mean PCF was 26.22%. The variance was 11.58.
The recommended PCF range of 30-40% was used in comparison. These results can be found
below in Table 6. A gender-specific analysis could not be performed on Group 1, as there was a
low female to male ratio (1:8).
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Table 6: Results for PCF* 95% Confidence Intervals for Group 1
Group

Measure

Mean

Variance

(%)

Group 1

PCF

26.22

Lower

Upper

Recommended

confidence

confidence

(%)

limit (%)

limit (%)

23.37

29.06

11.58

30-40

*PCF: Percentage of Fat Coming from Fat

Group 2
To compare participant data to the recommended PCF range (25-35%), a 95% confidence
interval was computed. The results, which were a mean of 25.66%, a variance of 34.75, a lower
confidence limit. of 22.82%, and an upper confidence limit of 28.50%, can be seen in Table 7.
As represented in Table 7, out of the 19 participants in Group 2, 11 (57.9%) were male
(Group 2M) and 8 (42.1%) were female (Group 2F). Group 2M had mean and variance results of
23% and 6.24. The lower and upper confidence limits were 21.72% and 25.08%, respectively.
For Group 2F, the results were a mean of 28.87%, variance of 67.14, lower confidence limit of
22.02%, and an upper confidence limit of 35.72%.
Table 7: Results for PCF* 95% Confidence Intervals for Group 2, 2M**, and 2F***
Group

Measure

Mean

Variance

(%)

Lower

Upper

Recommended

confidence

confidence

(%)

limit (%)

limit (%)

Group 2

PCF

25.66

34.75

22.82

28.50

25-35

Group 2M

PCF

23

6.24

21.72

25.08

25-35

Group 2F

PCF

28.87

67.14

22.02

35.72

25-35

*PCF: Percentage of Calories Coming from Fat
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Group 3

The mean PCF for Group 3 was 27.88%. The variance, lower confidence limit, and upper
confidence limit computed were 24.39, 25.50%, and 30.26%, respectively. The recommended
range, used for comparison purposes, was 20-35%. The results of the 95% confidence interval
performed on Group 3 can be seen in Table 8.
Six (31.6%) males (Group 3M) and thirteen (68.4%) females (Group 3F) made up Group
3 (Table 8). The results for Group 3M included a mean of 26.92%, a variance of 56.50, a lower
confidence limit of 19.03%, and an upper confidence limit of 34.81%. For Group 3F, the mean
was 28.80% and the variance was 19.85. The lower and upper confidence limits were 26.10%
and 31.49%.
Table 8: Results for PCF* 95% Confidence Intervals for Group 3, 3M, and 3F
Group

Measure

Mean

Variance

(%)

Lower

Upper

Recommended

confidence

confidence

(%)

limit (%)

limit (%)

Group 3

PCF

27.88

24.39

25.50

30.26

20-35

Group 3M

PCF

26.92

56.50

19.03

34.81

20-35

Group 3F

PCF

28.80

19.85

26.10

31.49

20-35

*PCF: Percentage of Calories Coming from Fat

95% Confidence Intervals Comparing BMI, BMI%, and WPL to Recommended
This study was to perform analyses on both genders in Group 1, 2, and 3; however,
Group 1 was not analyzed for gender differences because there was only 1 female so no estimate
of variance could be obtained.
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Group 1a
As shown in Figure 4, a healthy weight is indicated by a weight per length value between
the 5th and <85th percentile. This percentile range was compared to participant data by use of a
95% confidence interval. The mean WPL value for these six participants was 80.16%. The
variance was 303.5. The lower and upper limits were 61.88% and 98.44%. These results can be
found in Table 9.
Table 9: Results for WPL* 95% Confidence Interval for Group 1a
Group

Group 1a

Measure

Mean (%)

WPL

80.16

Variance

Lower

Upper

Recommended

Confidence

Confidence

WPL for Healthy

Limit (%)

Limit (%)

Individuals (%)

61.88

98.44

5th to <85th

303.5

*WPL: Weight Per Length

Group 1b
The recommended BMI% range for a healthy weight is 5th to <85th, which was used in a
95% confidence interval for comparison purposes. As seen in Table 10, the mean and variance
for these six participants were 66.91% and 689.48, respectively; the lower and upper confidence
limits were 39.36% and 94.47%, respectively.
Table 10: Results for BMI%* 95% Confidence Interval for Group 1b
Group

Group 1b

Measure Mean Variance

Lower

Upper

Recommended

(%)

Confidence

Confidence

BMI% for Healthy

Limit (%)

Limit (%)

Individuals (%)

39.36

94.47

5th to <85th

BMI%

66.91

689.48

*BMI%: Body Mass Index Percentile
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Group 2
A 95% confidence interval was computed to compare BMI% values to the recommended
BMI% for the nineteen participants in Group 2. The following results can be found in Table 11
below. The lower and upper confidence limits were found to be 51.43% and 76.88%, while the
mean BMI% was 64.16% and the variance was 696.84.
The confidence interval results for Group 2M include: a mean of 56.97%, variance of
786.71, lower confidence limit of 38.12%, and an upper confidence limit of 75.81%. The results
for Group 2F were a mean was 74.04%, variance of 475.09, lower confidence limit of 55.82%,
and upper confidence limit of 92.26%.
Table 11: Results for BMI%* 95% Confidence Intervals for Group 2, 2M, and 2F
Group

Measure

Mean

Variance

(%)

Lower

Upper

confidence confidence
limit (%)

Recommended
BMI% for

limit

Healthy

(%)

Individuals (%)

Group 2

BMI%

64.16

696.84

51.43

76.88

5th to <85th

Group 2M

BMI%

56.97

786.71

38.12

75.81

5th to <85th

Group 2F

BMI%

74.04

475.09

55.82

92.26

5th to <85th

*BMI%: Body Mass Index Percentile

Group 3
Through computation of a 95% confidence interval, BMI values for nineteen participants
were compared to the recommended BMI value. As shown in Table 12, the mean, variance,
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lower confidence limit, and upper confidence limit computed was 27.68 kg/m2, 82.75, 23.30
kg/m2, and 32.07 kg/m2, respectively.
For Group 3M, the mean was 25.42 kg/m2 and the variance was 27.19. The lower and
upper confidence limits were 19.95 kg/m2 and 30.90 kg/m2 for this group. For Group 3F, the
mean and variance were 29.51 kg/m2 and 109.92, while the lower and upper confidence limits
were 22.85 kg/m2 and 36.17 kg/m2.

Table 12: Results for BMI* 95% Confidence Intervals for Group 3, 3M, and 3F
Group

Measure

Mean

Variance

(kg/m2)

Lower

Upper

confidence confidence

Recommended
BMI for Healthy

limit

limit

Individuals

(kg/m2)

(kg/m2)

(kg/m2)

Group 3

BMI

27.68

82.75

23.30

32.07

18.5-24.9

Group 3M

BMI

25.42

27.19

19.95

30.90

18.5-24.9

Group 3F

BMI

29.51

109.92

22.85

36.17

18.5-24.9

*BMI: Body Mass Index

Individual T-Tests: Comparison to the Lower and Upper Limits of the PCF Recommended
Range
Alternative and null hypotheses were formed to determine if each group’s mean PCF was
below, within, or above the lower and upper limits of each recommendation range. The null
hypotheses, H0, for each analyses hypothesized that the mean PCF fell within the recommended
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range. The alternative hypotheses, H1, either stated that the mean PCF for each group fell above
the upper limit (H1-a) or below the lower limit (H1-b) of the recommended range.
Group 1
As shown in Table 13, the p-values for Group 1 were 1.0 (100%), when H0 was compared
to H1-a and 0.0008 (0.08%) when H0 was compared to H1-b.
Table 13: Results for PCF* Individual T-Tests for Group 1
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 1

H0: mean PCF intake

H1-a: mean PCF

[30,40]

intake > 40

H0: mean PCF intake

H1-b: mean PCF

[30,40]

intake < 30

1.0

0.0008

*PCF: Percentage of Calories Coming from Fat

Group 2, 2M, and 2F
Shown in Table 14, the results for Group 2 included a p-value of 1.0 (100%) when H0
was compared to H1-a and 0.302 (30.2%) when H0 was compared to H1-b. The p-value for Group
2M was 1.0 (100%) when the H0 was compared to H1-a. When comparing the H0 to H1-b, the pvalue result was 0.03 (3%). After analyzing the mean PCF value of Group 2F, the p-value was
0.96 (96%) when comparing H0 to H1-a, and 0.89 (89%) when comparing H0 to H1-b.
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Table 14: Results for PCF* Individual T-Tests for Group 2, 2M, and 2F
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 2

Group 2M

Group 2F

H0: mean PCF intake

H1-a: mean PCF

[25,35]

intake > 35

H0: mean PCF intake

H1-b: mean PCF

[25,35]

intake <25

0.302

H0: mean PCF intake

H1-a: mean PCF

1.0

[25,35]

intake > 35

H0: mean PCF intake

H1-b: mean PCF

[25,35]

intake <25

H0: mean PCF intake

H1-a: mean PCF

[20,35]

intake > 35

H0: mean PCF intake

H1-b: mean PCF

[20,35]

intake < 20

1.0

0.03

0.96

0.89

*PCF: Percentage of Calories Coming from Fat

Group 3, 3M, and 3F
For Group 3, a p-value of 1.0 (100%) resulted when H0 was tested against H1-a and also
when tested against H1-b. The results found for Group 3M and Group 3F were consistent with
Group 3’s findings, as shown in Table 15.
Table 15: Results for PCF* Individual T-Tests for Group 3, 3M, and 3F
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 3

H0: mean PCF intake

H1-a: mean PCF intake

[20,35]

> 35

PCF: Percentage of Calories Coming from Fat

23

1.0

Table 15 (continued)
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 3M

Group 3F

H0: mean PCF* intake

H1-a: mean PCF intake

[20,35]

> 35

H0: mean PCF intake

H1-b: mean PCF intake

[20,35]

< 20

H0: mean PCF intake

H1-a: mean PCF intake

[20,35]

> 35

H0: mean PCF intake

H1-b: mean PCF intake

[20,35]

< 20

1.0

1.0

1.0

1.0

*PCF: Percentage of Calories Coming from Fat

To compare data between male and participants, a null hypothesis, H0: mean percent fat
of males = mean percent fat of females, was tested to the alternative hypothesis, H1: the mean
percent fat of males ≠ mean percent fat of females. As shown in Table 16, the p-value for Group
2 was 0.1053 (15.3%), while the p-value for Group 3 was 0.589 (58.9%).

Table 16: Results for PCF* Individual T-Tests Between Genders
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 2: M** vs F***

Group 3: M vs F

H0: mean PCF of M =

H1: the mean PCF of M 0.1053

mean PCF of F

≠ mean PCF of F

H0: mean PCF of M =

H1: the mean PCF of M 0.589

mean PCF of F

≠ mean PCF of F

*PCF: Percentage of Calories Coming from Fat
**M: Males
***F: Females
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Individual T-Tests: Comparison to the Obesity Determining BMI

Individual t-tests were conducted to determine the presence of obesity in each age group.
The individual t-test performed on Group 1a tested the null hypothesis, H0: mean weight per
length ≤ 95, to the alternative hypothesis of H1: mean weight per length > 95. Shown in Table
17, the resulting p-value was 0.954 (95.4%). For Group 1b, as well as Group 2, an individual ttest tested a null hypothesis of H0: mean BMI% ≤ 95 to an alternative hypothesis of H1: mean
BMI% > 95. As shown in Table 17, the p-value for Group 1b was 0.976 (97.6%) and as shown in
Table 18, the p-value for Group 2 was 1.0 (100%). The individual t-tests for both Group 2M and
Group 2F participants resulted in the same p-values, which was 0.999 (99.9%), as shown in
Table 20.
Table 17: Results for WPL* and BMI%** Individual T-Tests for Group 1a and 1b
Group

Null Hypothesis

Alternative Hypothesis

p-value

Group 1a

H0: mean WPL ≤ 95

H1: mean WPL > 95

0.954

Group 1b

H0: mean BMI% ≤ 95

H1: mean BMI% > 95

0.976

*WPL: Weight Per Length
**BMI%: Body Mass Index Percentile

Table 18: Results for BMI%* Individual T-Tests for Group 2, 2M, and 2F
Group

Null Hypothesis

Alternative Hypothesis

p-value

Group 2

H0: mean BMI% ≤ 95

H1: mean BMI% > 95

1.0

Group 2M

H0: mean BMI% ≤ 95

H1: mean BMI% > 95

0.999

Group 2F

H0: mean BMI% ≤ 95

H1: mean BMI% > 95

0.999

*BMI%: Body Mass Percentile
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An individual t-test using BMI values was used for Group 3. The null hypothesis, H0:
mean BMI  30 kg/m2, was tested against the alternative hypothesis, H1:mean BMI > 30 kg/m2.
The p-values for Group 3, Group 3M, and Group 3F (Table 19) were the same, which were 0.730
(73.0%).
Table 19: Results for BMI* Individual T-Tests for Group 3, 3M, and 3F
Group

Null Hypothesis

Alternative Hypothesis

p-value

Group 3

H0: mean BMI  30 kg/m2

H1:mean BMI > 30 kg/m2

0.730

Group 3M

H0: mean BMI  30 kg/m2

H1:mean BMI > 30 kg/m2

0.730

Group 3F

H0: mean BMI  30 kg/m2

H1:mean BMI > 30 kg/m2

0.730

*BMI: Body Mass Index

In order to compare the male and female participants in both Group 2 and Group 3, an
individual t-test was performed testing the null hypothesis, H0: mean BMI% of males = mean
BMI% of females to the alternative hypothesis, H1: mean BMI% of males ≠ mean BMI% of
females. As shown in Table 20, the resulting p-values were 0.169 (16.9%) for Group 2 and 0.286
(28.6%) for Group 3.
Table 20: Results for BMI%* and BMI** Individual T-Tests Between Genders
Group

Null Hypothesis

Alternative

p-value

Hypothesis
Group 2: M*** vs F****

Group 3: M vs F
*BMI%: Body Mass Index Percentile

H0: mean BMI% of M

H1: mean BMI% of M

= mean BMI% of F

≠ mean BMI% of F

H0: mean BMI of M =

H1: mean BMI of M ≠

mean BMI of F

mean BMI of F

****Females

**BMI: Body Mass Index
***M: Males
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0.169

0.286

CHAPTER 4
DISCUSSION AND CONCLUSIONS

PKU is a rare, autosomal recessive, metabolic disorder in which the essential amino acid
phenylalanine builds up in the body’s blood and tissues. This is the result of a defect in the PAH
enzyme, which is responsible for converting phenylalanine to tyrosine. A buildup of
phenylalanine can lead to serious, irreversible complications, such as memory loss, epilepsy, and
developmental delay. To prevent these complications, a life-long natural protein restricted diet is
recommended, as phenylalanine is found in protein.17,28,38 The intake of fat is a minor concern
for those following the PKU diet; however, higher intakes of fat are strongly associated with
obesity and CVD.16 The aim of this study was to investigate the potential risk of CVD in the
PKU population by analyzing their dietary fat intake and, depending on age, BMI, BMI%, or
WPL.
Group 1
The mean PCF, lower confidence limit, and upper confidence limit fell below the range
for participants in the 1-3 age group. The upper confidence limit fell 0.94% away from the lower
limit (30%) of the PCF recommendation range. Consistent with this finding, the alternative
hypothesis (H1-b: mean PCF intake < 30) was accepted (Table 21). This study showed that
individuals diagnosed with PKU between the ages of 1-3 years are at a high risk for fat
deficiencies. Despite this, previous research has suggested that along with table food, these
individuals are also consuming high fat, high caloric formulas,8 providing more means for
individuals to meet their nutrient needs.
Both WPL and BMI% were analyzed in Group 1 as this group was further divided into
Group 1a and Group 1b. In this study, participants in Group 1a had a mean WPL percentile
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representing a healthy weight. However, the upper confidence limit was greater than the 95th
percentile; therefore, categorized as obese.
Consistent with Group 1a’s findings, the mean BMI % value and lower confidence limit
fell within normal limits; however, the upper confidence limit fell within the overweight
category. Although this study’s results indicated that participants in Group 1a and 1b are able to
maintain healthy weights and consume low dietary fat intakes, the variance and upper limits
suggest that participants within this age group are at risk for being obese. This study also showed
that participants 2 years and younger had higher PCF values, indicating higher fat consumptions
than those older than 2 years old.

Table 21: Conclusions to Individual T-Tests for Group 1, 1a, and 1b
Age Group

Null Hypothesis

Alternative

p-value

Conclusion

1.0

Can’t reject the

Hypothesis
Group 1

Group 1a

Group 1b

H0: mean PCF*

H1: mean PCF

intake [30,40]

intake > 40

H0: mean PCF

H1: mean PCF

intake [30,40]

intake < 30

H0: mean

H1: mean WPL >

WPL**≤ 95

95

H0: mean

H1: mean BMI%

BMI%*** ≤ 95

> 95

null hypothesis
0.0008

Reject the null
hypothesis

0.954

Can’t reject the
null hypothesis

0.976

Can’t reject the
null hypothesis

*PCF: Percentage of Calories Coming from Fat
**WPL: Weight Per Length
***BMI%: Body Mass Percentile

Group 2
Although the mean PCF and upper confidence limit for participants in Group 2 fell within
their recommended range, the lower confidence limit, 22.82%, did not. The mean PCF value fell

28

within the range by 0.66%. Since the mean PCF indicated that 4-18 year olds with PKU were
able to consume adequate amounts of fat, the null hypothesis (H0: mean % fat intake [25,35])
was not rejected (Table 22).
Similar to Group 2’s results, the null hypothesis for Group 2F was also accepted. This
study signified that PKU diagnosed, 4-19 old, females were able to meet their dietary fat
recommendation. However, the lower and upper confidence limits fell both below and above the
recommended range. As this result was likely due to individualized dietary habits, this study
reflected that the amount of fat that these participants consumed were more varied, falling under,
between, or above the range. Females in this age group had higher mean PCF values than the
males. Not meeting recommendations, Group 2M had a mean PCF value that fell 2% from the
lower limit of their range. The upper confidence limit for Group 2M met the lower
recommendation, but only by 0.08%; therefore, the alternative hypothesis (H1: mean % fat intake
<25) was accepted (Table 22).
The mean BMI% values for Group 2, Group 2F, and Group 2M all fell within the
recommended percentile range of 5th to <85th. Therefore, the null hypothesis (H0: mean BMI% of
males ≤ 95) for each of these three groups was accepted. Out of these three groups, although
having the greatest variance, Group 2M’s mean BMI% was the lowest. Females showed having
the highest BMI%, with an upper confidence limit falling above the recommendation by 7.26%.
This study not only showed that this age group was able to consume adequate fat intakes and
maintain a healthy weight, but also, females were at a greater risk than males for excessive PCF
and BMI% values. As mean BMI and PCF values for Group 2, Group 2M, and Group 2F fell
within the recommended ranges, an association between fat intake and BMI was identified.
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Table 22: Conclusions to Individual T-Tests for Group 2, 2M, and 2F
Group

Null Hypothesis

Alternative Hypothesis

Group 2

H0: mean PCF*

H1-a: mean PCF intake >

intake [25,35]

35

1.0

null hypothesis

H0: mean PCF

H1-b: mean PCF intake

0.302

Can’t reject the

intake [25,35]

<25

Group 2

p-value

Can’t reject the

null hypothesis

H0: mean BMI%** H1: mean BMI% > 95

1.0

≤ 95
Group 2M

Can’t reject the
null hypothesis

H0: mean PCF

H1-a: mean PCF intake >

intake [25,35]

35

H0: mean PCF

H1-b: mean PCF intake

intake [25,35]

<25

H0: mean BMI%

H1: mean BMI% > 95

1.0

Can’t reject the
null hypothesis

0.03

Reject the null
hypothesis

0.999

≤ 95
Group 2F

Conclusion

Can’t reject the
null hypothesis

H1-a: mean PCF intake >

intake [20,35]

35

null hypothesis

H0: mean PCF

H1-b: mean PCF intake < 0.89

Can’t reject the

intake [20,35]

20

null hypothesis

H0: mean BMI%

H1: mean BMI% > 95

≤ 95

0.96

Can’t reject the

H0: mean PCF

0.999

Can’t reject the
null hypothesis

*PCF: Percentage of Fat Coming from Fat
**BMI%: Body Mass Index Percentile

Group 3
The highest PCF and BMI values were found in Group 3, the oldest age group tested in
this study. The mean PCF, lower confidence limit, and upper confidence limit for Group 3 were
in the middle of the recommended PCF range, which was consistent to the results for both Group
3M and Group 3F. The only value that did not fall within the range was the lower confidence
limit for Group 3M, which fell below by 0.97%. This indicated that Group 3M consumed the
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lowest amount of dietary fat. Showing strong correlation, not only did Group 3M have the lowest
PCF values, but also the lowest BMI values when compared to Group 3M and Group 3F. The
mean BMI values for Group 3, Group 3M, and Group 3F all categorized as overweight, falling
between the BMI range of 25.0-29.9 kg/m2. More so, the upper confidence limit for this group
fell within the obesity category. As the mean values were < 30 kg/m2, the null hypotheses (H0:
mean BMI  30 kg/m2) were accepted (Table 23).
Table 23: Conclusions to Individual T-Tests for Group 3, 3M, and 3F
Group

Null Hypothesis

Alternative Hypothesis

p-value

Conclusion

Group 3

H0: mean PCF*

H1-a: mean PCF intake >

1.0

Can’t reject the null

intake [20,35]

35

hypothesis

H0: mean PCF

H1-b: mean PCF intake < 1.0

Can’t reject the null

intake [20,35]

20

hypothesis

H0: mean BMI**

H1:mean BMI > 30

 30 kg/m2

kg/m2

H0: mean PCF

H1-a: mean PCF intake >

intake [20,35]

35

hypothesis

H0: mean PCF

H1-b: mean PCF intake < 1.0

Can’t reject the null

intake [20,35]

20

hypothesis

H0: mean BMI 

H1:mean BMI > 30

30 kg/m2

kg/m2

H0: mean PCF

H1-a: mean PCF intake >

intake [20,35]

35

hypothesis

H0: mean PCF

H1-b: mean PCF intake < 1.0

Can’t reject the null

intake [20,35]

20

hypothesis

H0: mean BMI 

H1:mean BMI > 30

30 kg/m2

kg/m2

Group 3M

Group 3F

0.730

Can’t reject the null
hypothesis

1.0

0.730

Can’t reject the null

Can’t reject the null
hypothesis

1.0

0.730

Can’t reject the null

Can’t reject the null
hypothesis

*PCF: Percentage of Calories Coming from Fat
**BMI: Body Mass Index
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Although the recommended fat intakes for individuals with PKU are the same as for the
healthy population,6 this study set out to determine if the PKU population consumed higher
amounts of fat due to their food restrictions. A study analyzed the glycemic index, glycemic
load, and metabolic profile of twenty-one PKU diagnosed individuals and established that these
individuals consumed a high intake of carbohydrate and fiber and a low intake of fat and
protein.39 Consistent to these findings,39 an excessive intake of fat was not observed in this study.
However, older individuals, especially those within the 19-50 age group, were likely to consume
higher amounts of fat in their diet than those of younger ages.
Additionally, a previous study, which looked at the connection between fat-free mass,
resting metabolic rate, and energy intake, determined that men, having a higher amount of fatfree mass, consume more food than women.40 This study’s findings were inconsistent with those
of the previously mentioned study’s findings as higher fat intakes were identified in females in
both Group 2 and Group 3. However, as shown through the individual t-tests, which compared
mean PCF values between males and females within Groups 2 and 3, the null hypothesis was not
rejected, meaning that PCF values are similar between genders. As both values fell within the
normal range for PCF, this result shows relevance.
An interest in the dietary habits of PKU diagnosed individuals has recently arisen,
specifically in regards to obesity prevalence.24,43 Individuals with PKU are introduced to an
atypical lifestyle at a young age,25 such as being on phenylalanine-free formulas and protein
restricted diets. Substituting low-protein foods and adult formulas for high-caloric foods and
high-fat infant formulas are believed to be reasons to which PKU individuals are predisposed to
obesity.21
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As a previous studies found, females with PKU have a higher prevalence of obesity than
males.29,30 Consistent with another study,29 this study found BMI values were higher not only in
females, but also in older individuals. In the analyses for Group 3, Group 3M, and Group 3F, all
mean BMI values were categorized as overweight, coming <5% away from the obesity category.
The upper confidence limit for Group 3, Group 3M, and Group 3F were all within the obesity
category, which indicated that obesity is a risk commonly seen in PKU diagnosed individuals
between the ages of 19-50 years. Mean BMI% values for participants in Group 1a, Group 1b,
Group 2, Group 2M, and Group 2F were all found to be within normal limits; therefore, the risk
for obesity within younger aged PKU diagnosed individuals was not indicated. However, this
study did find that although the mean BMI% value fell within the recommended range,
participants in this study younger than the age of 2 years were at the higher end of the
recommended range, with an upper limit that fell within the obesity category. As individuals in
Group 1b had an upper confidence limit falling within the overweight category, it was indicated
that participants in Group 1 were shown to be at a greater potential risk for obesity.
Fat intakes and obesity are strongly associated and are two risk factors for CVD.41,43 The
type of fat consumed has a greater affect on increasing the risk of CVD than does the amount of
fat.20,41 However, both the presence of adipose tissue and obesity have been found to increase
CVD risk through certain mechanisms, such as inflammation, oxidative stress, and endothelial
dysfunction.23 Moreover, one previous study indicated that a higher intake of fruits and
vegetables decreased the risk of CVD. As the PKU diet is plant based, compliant individuals are
likely to consume more fruits and vegetables. A previous study determined that an intake of 800
grams of fruits and vegetables has the effect of increasing CVD risk in individuals with PKU.42
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In conclusion, this study analyzed the relationship among dietary fat intake, BMI, BMI%,
WPL, obesity, and CVD within the PKU population. This study included participants between
the ages of 1-50 years and took into consideration gender differences. As none of the participant
groups had a mean PCF value that was higher than the recommended ranges, it was determined
that individuals with PKU do not consume an excessive fat intake. Furthermore, this study did
not observe obesity in any of the groups; however, the mean BMI for Group 3 fell within the
overweight category. Also, the mean WPL for Group 1a fell close to the upper limit of the
recommendation range, while the upper confidence limit fell above and therefore, categorized as
obese. Based on previous research, it was believed that PKU diagnosed individuals were going to
have a higher fat intake and higher BMI values because of their food restriction. However, this
study identified that individuals were able to consume adequate fat intakes and maintain healthy
weights while on the PKU diet. Therefore, this study determined that based on the studied
population, individuals with PKU are not at a greater risk for CVD.
Study Limitations
The first claimed limitation of this study is that three-day food records can be full of
estimations, inaccuracies, and human error. However, since three-day food records are easy and
straight-forward, it was the best method to obtain the information needed for this study. Also,
three-day food records were requested from participants at each appointment; however, five
individuals had 24-hour dietary food recalls (10 food records total) and two participants had 12hour dietary food recalls (two food records total). Three-day food records are a better
representation of food and nutrient consumption than one and two-day food records. Three-day
food records allow for a larger number and variety of food, giving a better indication of the
individual’s diet. Also, belonging to two individuals, two food records were noted during
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pregnancy. As pregnant women are on larger, stricter diets, the food records may not have
reflected their typical intake. Since technology is not always accurate, another limitation to this
study was the use of MetabolicPro, a well-utilized program for the analysis of dietary intakes.
MetabolicPro has a large yet incomplete library of foods. Therefore, some foods were replaced
by close equivalents, potentially altering the results. Another study limitation is that although
accurate scales were used for anthropometric measurements, human error must still be
considered. Also, inaccuracies are likely in measurements taken on younger patients as it may
have been harder to keep them still for accurate readings. Any inaccurate measurements would
alter BMI, BMI%, and WPL calculations. Additionally, a gender-specific analysis was initially
to be performed on each of the three groups; however, this was not done on Group 1 as the ratio
of females to males was low. Therefore, this study signifies that the data collected on males and
females are only on those between the ages of 4 and 50. Lastly, this study wants to acknowledge
that the plan was to collect ten BMI, BMI%, or WPL and ten PCF values on all participants;
however, as data collection began, it was determined not possible. This data reflects the study
population well; however, some individuals may have had less data than others. The average of
measurements was taken for each individual to avoid the assumption of independence.
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Institutional Review Board
910 Madison Avenue, Suite 600
Memphis, TN 38163
Tel: (901) 448-4824
June 28, 2017

NADINE ASSAF, MS
UTHSC - COM - Boling Center for Developmental Disabilities
Re: 17-05366-XM UM
Study Title: The Analysis of Dietary Fat Intakes, Obesity, and Risk of Cardiovascular Disease for
Individuals Diagnosed With Phenylketonuria [UTHSC Reviewing IRB]
Dear Ms. ASSAF:
The Administrative Section of the UTHSC Institutional Review Board (IRB) has received your written
acceptance of and/or response dated June 27, 2017 to the provisos outlined in our correspondence of June
27, 2017 concerning the application for the above referenced project.
The IRB determined that your application is eligible for exempt review under 45CFR46.101 (b) (4): The
collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens,
if these sources are publicly available or if the information is recorded by the investigator in such a manner
that subjects cannot be identified, directly or through identifiers linked to the subjects. The use of children
as subjects is approved under 45 CFR 46.404. In accord with 45 CFR 46.116(d), informed consent is
waived. Your application has been determined to comply with proper consideration for the rights and
welfare of human subjects and the regulatory requirements for the protection of human subjects. Therefore,
this letter constitutes full approval of your application (version 1.0) as submitted including:
•

Data Collection Workbook

All of the above were stamped IRB-approved on June 28, 2017. You must use the date-stamped
versions of the study documents. Date-stamped materials are available in the Informed Consent and
Other Project Documents folders in iMedRIS.
In addition, the request for waiver of HIPAA authorization in order to identify potential subjects and for the
collection of data for the study is approved in accord with the criteria and review procedures specified at 45
CFR 164.512(i)(2). The waiver applies to the medical records of patients at the Boling Center diagnosed
with PKU and seen between June 1, 2010 and May 31, 2017.
In the event that volunteers are to be recruited using solicitation materials, such as brochures, posters, webbased advertisements, etc., these materials must receive prior approval of the IRB.
Any alterations (revisions) in the protocol must be promptly submitted to and approved by the UTHSC
Institutional Review Board prior to implementation of these revisions. In addition, you are responsible for
reporting any unanticipated serious adverse events or other problems involving risks to subjects or others in
the manner required by the local IRB policy. Lastly, you must request to close your project when you have
completed data analysis. All of the above should be submitted to the IRB via the appropriate form in
iMedRIS.

Sincerely,
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